Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy

Antiviral Therapy

Volumn 19, Issue 7, 2014, Pages 637-643

  Huang, Yi Wen ^a,b,c,d   Hsu, Cheng Kai ^a   Lin, Shih Chang ^a,e   Wei, Shu Chen ^c   Hu, Jui Ting ^a,e   Chang, Han Yu ^a   Liang, Cher Wei ^c   Chen, Ding Shinn ^b,c   Chen, Pei Jer ^b,c   Hsu, Ping Ning ^b   Yang, Sien Sing ^a,b,d   Kao, Jia Horng ^b,c,f,g  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CD14 ANTIGEN; ENTECAVIR; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; MESSENGER RNA; PEGINTERFERON; TOLL LIKE RECEPTOR 9; VIRUS DNA; ALPHA INTERFERON; ANTIVIRUS AGENT; GUANINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENDER; GENE EXPRESSION; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PROSPECTIVE STUDY; PROTEIN EXPRESSION; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; HEPATITIS B, CHRONIC; IMMUNOLOGY; LIVER; METABOLISM; MIDDLE AGED; VIRUS LOAD;

ADULT; ANTIGENS, CD14; ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; GUANINE; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; MALE; MIDDLE AGED; MONOCYTES; PROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 9; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84920107813     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2762     Document Type: Article

References (28)

1. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2:395-403.
2. Chen DS. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993; 262:369-370.
3. Chisari F V, Ferrari C. Hepatitis B immunopathogenesis. Annu Rev Immunol 1995; 13:29-60.
4. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5:987-995.
5. Isogawa M, Robek MD, Furuichi Y, Chisari FV. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 2005; 79:7269-7272.
6. Huang Y W, Lin SC, Wei SC, et al. Reduced Toll-like receptor-3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antivir Ther 2013; 18:877-884.
7. Xie Q, Shen HC, Jia NN, et al. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9. Microbes Infect 2009; 11:515-523.
8. Xu Y, Hu Y, Shi B, et al. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 2009; 46:2640-2646.
9. Shi B, Ren G, Hu Y, Wang S, Zhang Z, Yuan Z. HBsAg inhibits IFN-alpha production in plasmacytoid dendritic cells through TNF-alpha and IL-10 induction in monocytes. PLoS ONE 2012; 7:e44900.
10. +) T cells and successful immunotherapy against chronic viral liver infection. Nat Immunol 2013; 14:574-583.
11. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45:507-539.
12. Janssen HL, Sonneveld MJ, Brunetto MR. Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B? Gut 2012; 61:641-645.
13. Lampertico P, Liaw YF. New perspectives in the therapy of chronic hepatitis B. Gut 2012; 61:i18-i24.
14. Yeh SH, Tsai CY, Kao JH, et al. Quantification and genotyping of hepatitis B virus in a single reaction by realtime PCR and melting curve analysis. J Hepatol 2004; 41:659-666.
15. Visvanathan K, Skinner NA, Thompson AJ, et al. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45:102-110.
16. Chen Z, Cheng Y, Xu Y, et al. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients. Clin Immunol 2008; 128:400-408.
17. Woltman AM, Op den Brouw ML, Biesta PJ, Shi CC, Janssen HL. Hepatitis B virus lacks immune activating capacity, but actively inhibits plasmacytoid dendritic cell function. PLoS ONE 2011; 6:e15324.
18. Ratnam DT, Sievert W, Visvanathan K. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B. Cell Immunol 2012; 279:109-115.
19. Martinet J, Dufeu-Duchesne T, Costa JB, et al. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection. Gastroenterology 2012; 143:1586-1596.
20. Wu J, Meng Z, Jiang M, et al. Hepatitis B virus suppresses Toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 2009; 49:1132-1140.
21. Tang TJ, Kwekkeboom J, Laman JD, et al. The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection. J Viral Hepat 2003; 10:159-167.
22. Lv S, Wang J, Dou S, et al. Nanoparticles encapsulating HBV-CpG induce therapeutic immunity against hepatitis B virus infection. Hepatology 2014; 59:385-394.
23. Sørensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, Paludan SR. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol 2008; 181:8604-8612.
24. Sato A, Linehan MM, Iwasaki A. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc Natl Acad Sci U S A 2006; 103:17343-17348.
25. Zucchini N, Bessou G, Traub S, et al. Cutting edge: overlapping functions of TLR7 and TLR9 for innate defense against a herpes-virus infection. J Immunol 2008; 180:5799-5803.
26. Delaloye J, Roger T, Steiner-Tardivel QG, et al. Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome. PLoS Pathog 2009; 5:e1000480.
27. Wang K, Liu H, He Y, et al. Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure. Hum Immunol 2010; 71:950-956.
28. Zhou J, Huang Y, Tian D, Xu D, Chen M, Wu H. Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads. J Huazhong Univ Sci Technolog Med Sci 2009; 29:313-317.